Impax Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IMPAX PHARMS
IMPAX PHARMS has six approved drugs.
There is one tentative approval on IMPAX PHARMS drugs.
Drugs and US Patents for Impax Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Pharms | SOTALOL HYDROCHLORIDE | sotalol hydrochloride | TABLET;ORAL | 075663-001 | Nov 7, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Impax Pharms | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 076449-002 | May 27, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Impax Pharms | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET, EXTENDED RELEASE;ORAL | 076745-002 | May 9, 2007 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

